Anagenex Company
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Investors
Connections from
Headquarters:
United States
Total Funding:
37200000.0
Founded Date:
2020-01-01
Last Funding Type:
Series A
Investors Number:
7.0
Last Funding Date:
2022-06-08
Funding Status:
Early Stage Venture
Industry:
Early Drug Development